Showing 12 out of 2322 items
- Indigenous peoples in Canada experience social and health disparities due to the ongoing effects of racism, colonization, and intergenerational trauma from forced family separation by the residential…
- Symtuza contains four medicines - darunavir, cobicistat, tenofovir alafenamide (TAF) and FTC.
- Isentress HD contains the anti-HIV drug raltegravir. Isentress HD belongs to the class of drugs called integrase inhibitors.
- 2018 has been a pivotal year for HIV and hepatitis C prevention, testing and treatment. Researchers and clinicians have pioneered game-changing HIV ...
- Prevention in FocusA review of the available evidence on whether PrEP could help or hinder STI prevention efforts among gbMSM in Canada.
- Prevention in FocusWe speak to service providers and community workers across the country about stigma, STIs, and monitoring for gbMSM on PrEP.
- Prevention in FocusAn exploration of the concept of micro-elimination of hepatitis C, sharing results from international initiatives and modelling studies.
- Prevention in FocusA look at the phenomenon of party and play (PnP) in Canada, its associated risks, and how service providers can support gbMSM who use drugs during sex.
- Prevention in FocusA review of the evidence showing the benefits of opioid agonist therapy (OAT) and a look at some ways to facilitate better access in Canada.